Buckingham Research upgraded shares of Ingevity (NYSE:NGVT) from a neutral rating to a buy rating in a research note released on Thursday, Marketbeat.com reports. They currently have $92.00 target price on the stock, up from their previous target price of $64.00.
Several other equities analysts have also weighed in on the company. Jefferies Group lifted their price target on Ingevity to $92.00 and gave the company a buy rating in a research note on Thursday. Loop Capital lowered Ingevity from a buy rating to a hold rating and set a $80.00 price target for the company. in a research note on Tuesday, February 27th. SunTrust Banks restated a buy rating and issued a $90.00 price target on shares of Ingevity in a research note on Friday, February 23rd. Zacks Investment Research upgraded Ingevity from a hold rating to a strong-buy rating and set a $89.00 price target for the company in a research note on Saturday, February 24th. Finally, KeyCorp restated an overweight rating and issued a $89.00 price target (up previously from $78.00) on shares of Ingevity in a research note on Friday, February 23rd. One analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $86.13.
Ingevity (NYSE NGVT) opened at $81.49 on Thursday. The company has a quick ratio of 1.36, a current ratio of 2.41 and a debt-to-equity ratio of 1.60. Ingevity has a 52 week low of $53.62 and a 52 week high of $82.10. The firm has a market capitalization of $3,428.69, a PE ratio of 27.44, a P/E/G ratio of 1.89 and a beta of 0.93.
A number of large investors have recently bought and sold shares of the business. BlackRock Inc. increased its stake in Ingevity by 4.9% during the 4th quarter. BlackRock Inc. now owns 5,415,950 shares of the company’s stock worth $381,661,000 after buying an additional 253,722 shares in the last quarter. Channing Capital Management LLC increased its stake in Ingevity by 11.4% during the 4th quarter. Channing Capital Management LLC now owns 1,038,974 shares of the company’s stock worth $73,216,000 after buying an additional 105,991 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Ingevity by 1.0% during the 4th quarter. Bank of New York Mellon Corp now owns 687,517 shares of the company’s stock worth $48,449,000 after buying an additional 6,622 shares in the last quarter. Lazard Asset Management LLC increased its stake in Ingevity by 1.4% during the 4th quarter. Lazard Asset Management LLC now owns 513,444 shares of the company’s stock worth $36,182,000 after buying an additional 6,908 shares in the last quarter. Finally, Copper Rock Capital Partners LLC increased its stake in Ingevity by 29.3% during the 4th quarter. Copper Rock Capital Partners LLC now owns 421,298 shares of the company’s stock worth $29,946,000 after buying an additional 95,350 shares in the last quarter. Institutional investors own 88.86% of the company’s stock.
WARNING: This article was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3256782/ingevity-ngvt-upgraded-at-buckingham-research.html.
Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.